This inventor holds 1 USPTO granted patent. Top assignees: Astellas Pharma Gmbh, Modalis Therapeutics Corporation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 424 
1 out of 6 Years Active: 2022
Title: Nidhi Khanna: Innovator in Muscular Dystrophy Treatment
Introduction
Nidhi Khanna is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of muscular dystrophy. Her innovative approach focuses on targeting the utrophin gene, which has the potential to transform therapeutic strategies for this debilitating condition.
Latest Patents
Nidhi Khanna holds a patent for a method aimed at treating muscular dystrophy by targeting the utrophin gene. The patent, titled "Polynucleotides comprising the following base sequences," represents a breakthrough in genetic therapy and showcases her commitment to advancing medical science. She has 1 patent to her name.
Career Highlights
Throughout her career, Nidhi has worked with notable companies in the pharmaceutical and biotechnology sectors. She has been associated with Astellas Pharma GmbH and Modalis Therapeutics Corporation, where she has contributed her expertise in developing innovative treatments.
Collaborations
Nidhi has collaborated with esteemed professionals in her field, including Eiji Yoshimi and Katsuro Yoshioka. These partnerships have further enhanced her research and development efforts, leading to advancements in therapeutic solutions.
Conclusion
Nidhi Khanna's work in the field of muscular dystrophy treatment exemplifies her dedication to innovation and improving patient outcomes. Her contributions are paving the way for future advancements in genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile